Poly(β-amino ester) as a carrier for si/shRNA delivery in lung cancer cells

Biomaterials

Volumn 29, Issue 16, 2008, Pages 2535-2547

  Jere, Dhananjay ^a   Xu, Cheng Xiong ^b   Arote, Rohidas ^a   Yun, Cheol Heui ^a   Cho, Myung Haing ^b   Cho, Chong Su ^a  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Akt protein; Gene silencing; Lung cancer; Non viral vector; Poly(amino ester); siRNA delivery

Indexed keywords

LUNG CANCER CELLS; POLY(AMINO ESTER); SIRNA DELIVERY;

AMINO ACIDS; BIODEGRADABILITY; MOLECULAR WEIGHT; RNA; TUMORS;

ESTERS;

ENHANCED GREEN FLUORESCENT PROTEIN; MACROGOL; ONCOPROTEIN; ONCOPROTEIN AKT1; POLY(BETA AMINO ESTER); POLYETHYLENEIMINE; POLYMER; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAFETY;

ADMINISTRATION, INHALATION; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG CARRIERS; ESTERS; GENE SILENCING; GREEN FLUORESCENT PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NECROSIS; POLYETHYLENEIMINE; POLYMERS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 40949100345     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.02.018     Document Type: Article

References (42)

1. In: Engelke D.R., and Rossi J.J. (Eds). RNA interference (2005), USA, Elsevier
2. Dykxhoorn D.M., and Lieberman J. Knocking down disease with siRNAs. Cell 126 2 (2006) 231-235
3. Amarzguioui M., Rossi J.J., and Kim D. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett 579 26 (2005) 5974-5981
4. Bolcato-Bellemin A.L., Bonnet M.E., Creusat G., Erbacher P., and Behr J.P. Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci U S A 104 41 (2007) 16050-16055
5. Devi G.R. siRNA-based approaches in cancer therapy. Cancer Gene Ther 13 9 (2006) 819-829
6. Lv W., Zhang C., and Hao J. RNAi technology: a revolutionary tool for the colorectal cancer therapeutics. World J Gastroenterol 12 29 (2006) 4636-4639
7. Pai S.I., Lin Y.Y., Macaes B., Meneshian A., Hung C.F., and Wu T.C. Prospects of RNA interference therapy for cancer. Gene Ther 13 6 (2006) 464-477
8. Takeshita F., and Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci 97 8 (2006) 689-696
9. Tong A.W. Small RNAs and non-small cell lung cancer. Curr Mol Med 6 3 (2006) 339-349
10. Tong A.W., Zhang Y.A., and Nemunaitis J. Small interfering RNA for experimental cancer therapy. Curr Opin Mol Ther 7 2 (2005) 114-124
11. Pang R.P., Zhou J.G., Zeng Z.R., Li X.Y., Chen W., Chen M.H., et al. Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway. Cancer Lett 251 2 (2007) 268-277
12. Sourbier C., Lindner V., Lang H., Agouni A., Schordan E., Danilin S., et al. The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy. Cancer Res 66 10 (2006) 5130-5142
13. Staal S.P. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci U S A 84 14 (1987) 5034-5037
14. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9 1 (2005) 59-71
15. Chen Y.L., Law P.Y., and Loh H.H. Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells. Cancer Res 64 23 (2004) 8723-8730
16. Dancey J.E. Molecular targeting: PI3 kinase pathway. Ann Oncol 15 Suppl. 4 (2004) iv233-39
17. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev 13 22 (1999) 2905-2927
18. Heron-Milhavet L., Franckhauser C., Rana V., Berthenet C., Fisher D., Hemmings B.A., et al. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol 26 22 (2006) 8267-8280
19. Meng Q., Xia C., Fang J., Rojanasakul Y., and Jiang B.H. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal 18 12 (2006) 2262-2271
20. Testa J.R., and Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A 98 20 (2001) 10983-10985
21. Grayson A.C., Doody A.M., and Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res 23 8 (2006) 1868-1876
22. Kim H.W., Park I.K., Cho C.S., Lee K.H., Beck Jr. G.R., Colburn N.H., et al. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 64 21 (2004) 7971-7976
23. Thomas M., Lu J.J., Chen J., and Klibanov A.M. Non-viral siRNA delivery to the lung. Adv Drug Deliv Rev 59 2-3 (2007) 124-133
24. Werth S., Urban-Klein B., Dai L., Hobel S., Grzelinski M., Bakowsky U., et al. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J Control Release 112 2 (2006) 257-270
25. Grzelinski M., Urban-Klein B., Martens T., Lamszus K., Bakowsky U., Hobel S., et al. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther 17 7 (2006) 751-766
26. Swami A., Kurupati R.K., Pathak A., Singh Y., Kumar P., and Gupta K.C. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Biochem Biophys Res Commun 362 4 (2007) 835-841
27. Mao S., Neu M., Germershaus O., Merkel O., Sitterberg J., Bakowsky U., et al. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjug Chem 17 5 (2006) 1209-1218
28. Gary D.J., Puri N., and Won Y.Y. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 121 1-2 (2007) 64-73
29. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., and Park T.G. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release 116 2 (2006) 123-129
30. Zhang W., Yang H., Kong X., Mohapatra S., San Juan-Vergara H., Hellermann G., et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 11 1 (2005) 56-62
31. Anderson D.G., Lynn D.M., and Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl 42 27 (2003) 3153-3158
32. Kim T.I., Seo H.J., Choi J.S., Yoon J.K., Baek J.U., Kim K., et al. Synthesis of biodegradable cross-linked poly(beta-amino ester) for gene delivery and its modification, inducing enhanced transfection efficiency and stepwise degradation. Bioconjug Chem 16 5 (2005) 1140-1148
33. Little S.R., Lynn D.M., Ge Q., Anderson D.G., Puram S.V., Chen J., et al. Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A 101 26 (2004) 9534-9539
34. Wu D., Liu Y., Jiang X., Chen L., He C., Goh S.H., et al. Evaluation of hyperbranched poly(amino ester)s of amine constitutions similar to polyethylenimine for DNA delivery. Biomacromolecules 6 6 (2005) 3166-3173
35. Arote R., Kim T.H., Kim Y.K., Hwang S.K., Jiang H.L., Song H.H., et al. A biodegradable poly(ester amine) based on polycaprolactone and polyethylenimine as a gene carrier. Biomaterials 28 4 (2007) 735-744
36. Jere D, Yoo MK, Arote R, Kim TH, Cho MH, Nah JW, et al. Poly(amino ester) composed of poly(ethylene glycol) and aminosilane prepared by combinatorial chemistry as a gene carrier. Pharm. Res., in press, doi: 10.1007/s11095-007-9448--4.
37. Greenland J.R., Liu H., Berry D., Anderson D.G., Kim W.K., Irvine D.J., et al. Beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization. Mol Ther 12 1 (2005) 164-170
38. Park M.R., Han K.O., Han I.K., Cho M.H., Nah J.W., Choi Y.J., et al. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release 105 3 (2005) 367-380
39. Park M.R., Kim H.W., Hwang C.S., Han K.O., Choi Y.J., Song S.C., et al. Highly efficient gene transfer with degradable poly(ester amine) based on poly(ethylene glycol) diacrylate and polyethylenimine in vitro and in vivo. J Gene Med 10 2 (2007) 198-207
40. Sithanandam G., Fornwald L.W., Fields J., and Anderson L.M. Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. Oncogene 24 11 (2005) 1847-1859
41. Wang X., Le P., Liang C., Chan J., Kiewlich D., Miller T., et al. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther 2 11 (2003) 1085-1092
42. Lakka S.S., Gondi C.S., Yanamandra N., Olivero W.C., Dinh D.H., Gujrati M., et al. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23 27 (2004) 4681-4689